Targeting Endogenous Antioxidants to Prevent Cardiovascular Diseases

Por Wilson Tang, W. H.
Publicado em 2012

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome

Por Aghel, Arash, Wilson Tang, W. H.
Publicado em 2008

Role of Oxidative Stress in Disease Progression in Stage B Heart Failure

Por Bhimaraj, Arvind, Wilson Tang, W. H.
Publicado em 2011

Right Ventricular Afterload and the Role of Nitric Oxide Metabolism in Left-sided Heart Failure

Por Dupont, Matthias, Wilson Tang, W. H.
Publicado em 2013

Incorporating Common Biomarkers into the Clinical Management of Heart Failure

Por Halkar, Meghana, Wilson Tang, W. H.
Publicado em 2013

Intersections between Microbiome and Heart Failure: Revisiting the Gut Hypothesis

Por Nagatomo, Yuji, Wilson Tang, W. H.
Publicado no J Card Fail (2015)

Hemodialysis-induced Cardiovascular Disease

Por Ahmadmehrabi, Shadi, Wilson Tang, W. H.
Publicado no Semin Dial (2018)

Institute for Quality in Laboratory Medicine Series - Controversies in Laboratory Medicine: Insights Into B-type Natriuretic Peptide and N-terminal pro-B-type Natriuretic Peptide M...

Por Christenson, Robert H., Wilson Tang, W.H.
Publicado em 2006

The Gut Microbiome and its Role in Cardiovascular Diseases

Por Wilson Tang, W. H., Hazen, Stanley L.
Publicado no Circulation (2017)

Carbamylated Low Density Lipoprotein and Thrombotic Risk in Chronic Kidney Disease

Por Wilson Tang, W.H., Hazen, Stanley L.
Publicado no J Am Coll Cardiol (2016)

Dietary Metabolism, Gut Microbiota and Acute Heart Failure

Por Wilson Tang, W. H., Hazen, Stanley L.
Publicado no Heart (2016)

Advances in new therapeutic targets for atherosclerosis

Por Wilson Tang, W. H., Hazen, Stanley L.
Publicado no Nat Rev Cardiol (2017)

Contributory Role of Gut Microbiota and Their Metabolites Towards Cardiovascular Complications in Chronic Kidney Disease

Por Li, Daniel Y., Wilson Tang, W. H.
Publicado no Semin Nephrol (2018)

Utilizing Cardiac Biomarkers to Detect and Prevent Chemotherapy-induced Cardiomyopathy

Por Singh, Dhssraj, Thakur, Akanksha, Wilson Tang, W. H.
Publicado no Curr Heart Fail Rep (2015)

Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis

Por Li, Daniel, Kirsop, Jennifer, Wilson Tang, W. H.
Publicado no Curr Diab Rep (2015)

Contemporary Insights and Novel Treatment Approaches to Central Sleep Apnea Syndrome in Heart Failure

Por Grayburn, Ryan L., Kaka, Yaquta, Wilson Tang, W. H.
Publicado em 2014

Long-term Dietary Habits and Interventions in Solid Organ Transplantation

Por Zeltzer, Stuart M., Taylor, David O., Wilson Tang, W. H.
Publicado no J Heart Lung Transplant (2015)

Progressive Rise in Red Cell Distribution Width Is Associated with Disease Progression in Ambulatory Patients with Chronic Heart Failure

Por Cauthen, Clay A, Tong, Wilson, Jain, Anil, Wilson Tang, W. H.
Publicado em 2011

Cystatin C Identifies Patients with Stable Chronic Heart Failure at Increased Risk for Adverse Cardiovascular Events

Por Dupont, Matthias, Wu, Yuping, Hazen, Stanley L., Wilson Tang, W. H.
Publicado em 2012

Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications

Por Kim, Youn-Hyun, Nijst, Petra, Kiefer, Kathryn, Wilson Tang, W. H.
Publicado no Curr Heart Fail Rep (2017)